Lehigh Valley Health Network

Allentown, Pennsylvania 18105

16 studies enrolling now · 116 studies all time

What they study most

AAA, AAA - Abdominal Aortic Aneurysm, ALS, Acquired Immunodeficiency Syndrome, Acute Deep Partial Thickness Thermal Burns, Acute Exacerbation of COPD, Acute Ischemic Stroke Patients Receiving Reperfusion Therapy, Acute Leukemia, Adenocarcinoma - GEJ, Adenocarcinoma Gastric Stage IV With Metastases, Adult Solid Tumor, Advanced Non-small Cell Lung Cancer

Studies at this site

• Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) — Recruiting now
• Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease — Recruiting now
• Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia — Recruiting now
• A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer — Recruiting now
• Genomic Profiling in Cancer Patients — Recruiting now
• Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders. — Recruiting now
• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
• Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation — Recruiting now
• Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study — Recruiting now
• Transformative Research in Diabetic Nephropathy — Recruiting now
• Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease — Recruiting now
• PUSH-IT Continuing Enteral Feeds for Tracheostomy — Recruiting now
• Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy — Recruiting now
• JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization — Recruiting now
• Determining Whether Durvalumab in Combination With Radiation Therapy Can Prevent the Progression of Non-Small Cell Lung Cancer — Running, not enrolling
• Lead Evaluation for Defibrillation and Reliability Post Approval Study — Enrolling by invitation
• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function — Running, not enrolling
• A Study of Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors — Running, not enrolling
• HEALEY ALS Platform Trial - Master Protocol — Running, not enrolling
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors — Running, not enrolling
• A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors — Running, not enrolling
• Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer — Running, not enrolling
• Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation — Running, not enrolling
• Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies — Available (expanded access)
• Meclofenamate in Subjects With Recurrent or Progressive Brain Metastasis From Solid Tumor Primary — Running, not enrolling
• A Communication Tool to Improve Communication in the ICU — Running, not enrolling
• SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD) — Completed
• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — Running, not enrolling
• Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release — Available (expanded access)
• Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer — Running, not enrolling
• Vagus Nerve Stimulation for Moderate to Severe Rheumatoid Arthritis — Running, not enrolling
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS — Available (expanded access)
• Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open-label Extension for 6 Months in Patients With ALS — Running, not enrolling
• A Registry for Patients With Multifocal Ground Glass Opacities (GGOs) — Running, not enrolling
• Micra AV Transcatheter Pacing System Post-Approval Registry — Completed
• A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) — Completed
• A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer — Running, not enrolling
• Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma — Running, not enrolling
• A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease — Completed
• Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer — Completed
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260) — Completed
• Foley Balloon Study for Cervical Ripening - Cost Comparison Between Outpatient and Inpatient Cervical Ripening — Completed
• A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older — Completed
• Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma — Completed
• Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain — Completed
• DS-8201a in HER2-positive Gastric Cancer That Cannot Be Surgically Removed or Has Spread (DESTINY-Gastric02) — Completed
• A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease — Completed